Yescarta (axicabtagene ciloleucel)

pCPA File Number: 22494
Negotiation Status:
Active Negotiation
Indication(s):
The treatment of adult patients with relapsed or refractory grade 1, 2 or 3a follicular lymphoma (FL) after two or more lines of systemic therapy.
Sponsor/Manufacturer:
Gilead Sciences Canada Inc.
CADTH Project Number:
PG0314-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable